Lot Release Certificate View

Lot Release Number 2020-12-09-0319
FDA Registered Product/Generic Name Diphtheria, Tetanus, Pertussis (Acellular Component), Hepatitis B, Poliomyelitis (Inactivated) and Haemophilus influenzae Type B Conjugate Vaccine (Adsorbed) [DTap-IPV-HepB-Hib]
Brand Name Hexaxim
Dosage Strength Suspension for Injection
Dosage Form Suspension for Injection
Registration Number BR-919
Batch/Lot Number T3M60
Packaging Lot Packaging Lot: Box - T3M602V; PFS - T3M60; Needle (25G x 5/8") - 2003008 [ED: 2025-02-28]; Needle (23G x 1") - 2002051 [ED: 2025-01-31]
Product Expiration Date 31 August 2022
Issuance Date 11 December 2020